Literature DB >> 242028

On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.

R J Stawarz, H Hill, S E Robinson, P Setler, J V Dingell, F Sulser.   

Abstract

The effect of various antipsychotic drugs on the blockade of dopaminergic receptors in striatum and limbic forebrain was examined by establishing dose-response curves for the increase in HVA and for the antagonism of d-amphetamine-induced rotation in rats with unilateral lesions of the substantia nigra. A good quantitative correlation was found between dopaminergic blockade in the striatum as reflected by the ED100 for striatal HVA increase and the ED50 for rotational antagonism and the occurrence of extrapyramidal side effects in man. The ED100 for the increase in HVA in the limbic forebrain showed the same rank order of potency as those in the striatum: Haloperidol greater than primozide greater than chlorpromazine greater than thioridazine greater than clozapine. The results thus demonstrate a very good correlation between the degree of dopaminergic blockade and the increase of extrapyramidal side effects in man, but suggest the possibility of a dissociation between dopaminergic blockade and antipsychotic activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 242028     DOI: 10.1007/bf00421014

Source DB:  PubMed          Journal:  Psychopharmacologia


  24 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

3.  Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.

Authors:  M Ackenheil; H Beckmann; W Greil; G Hoffmann; E Markianos; J Raese
Journal:  Adv Biochem Psychopharmacol       Date:  1974

4.  Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

Authors:  R Matz; W Rick; H Thompson; S Gershon
Journal:  Curr Ther Res Clin Exp       Date:  1974-07

5.  Interaction of atropine-like drugs with dopamine-containing neurones in rat brain.

Authors:  M B Bowers; R H Roth
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

7.  [Pharmacological and neurochemical effects of clozapine (Leponex): new aspects in the drug therapy of schizophrenia].

Authors:  H R Bürki; W Ruch; H Asper; M Baggiolini; G Stille
Journal:  Schweiz Med Wochenschr       Date:  1973-12-01

8.  Effects of clozapine on cerebral catecholaminergic neurone systems.

Authors:  G Bartholini; W Haefely; M Jalfre; H H Keller; A Pletscher
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

Authors:  Y C Clement-Cormier; J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Effect of drugs used in psychoses on cerebral dopamine metabolism.

Authors:  R O'Keeffe; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

View more
  15 in total

1.  Dose-response curves of homovanillic acid in pre-frontal cortex and caudate following antipsychotic drugs: relation to clinical potencies.

Authors:  W H Chang; T Y Chen; H S Wu; W H Hu; E K Yeh
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

4.  The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.

Authors:  A R Cools; E P Prinssen; B A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

5.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.

Authors:  R D Ciaranello; R E Boehme
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

7.  Differential effects of haloperidol and clozapine on attention.

Authors:  M Cheal
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

9.  Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.

Authors:  L R Steranka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

10.  Differential effects of sulpiride and metoclopramide on brain. Homovanillic acid levels and shuttle box avoidance after systemic and intracerebral administration.

Authors:  Y Nishibe; Y Matsuo; T Yoshizaki; M Eigyo; T Shiomi; K Hirose
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.